President & CEO Kevin Davidson of BioDrain Medical, Inc. Conducts Exclusive Webcast Interview with The Green Baron Report

Jun 29, 2010, 07:00 ET from BioDrain Medical, Inc.

MINNEAPOLIS, June 29 /PRNewswire-FirstCall/ -- BioDrain Medical, Inc. (OTC Bulletin Board: BIOR), owner of the Streamway™ fully automated and FDA cleared fluid management system, announced today that its President & CEO Kevin Davidson has conducted an exclusive new audio-taped webcast interview so that BIOR shareholders and the investment community can learn more about the Company's recently developments and growth plans.  Unrestricted access to the webcast is now available on the "Webcasts" page at  This webcast is also available at, "Where Wall Street speaks to the World."

It is noted that The Green Baron Report also initiated coverage of BioDrain Medical, Inc. as a "Stock Pick" through a profile released yesterday, Monday, June 28, 2010 after the close of trading.  This report is available at website.  The 10-page report focuses on the benefits of BioDrain's Streamway™ System and how this recently FDA cleared product is ready for commercialization.

About BioDrain Medical, Inc.

BioDrain Medical, Inc. has a fully automated, patented, FDA cleared, surgical fluid management system that virtually eliminates Operating Room workers' exposure to blood, irrigation fluid and the related germs, viruses and diseases that are potentially found in the surgical environment.  

Today's manual surgical fluid handling methods of hand-carrying filled surgical fluid canisters and emptying these canisters is an exposure risk and an ineffective method for the handling of surgical fluid waste.  BioDrain's Streamway™ System fully automates the collection, measurement and disposal of surgical fluids resulting in: 1) reducing overhead costs to hospitals and surgical centers, 2) improving the Occupational State and Health Association (OSHA) and other regulatory compliance, and 3) improving the efficiency of the Operating Room (and thereby making surgeries more profitable).  

BioDrain products are currently being represented by approximately 30 independent professional sales representatives that cater to the needs of hospitals across the country.  For more information, see

About The Green Baron Report

The Green Baron Report is a subsidiary of Evergreen Marketing. The Green Baron Report is an internet stock market newsletter that focuses on low priced stocks that appear to have significant upside potential. For more information about Evergreen Marketing, Inc. and their subsidiary The Green Baron Investors Society visit them on the web at and  Our disclaimer can be viewed at  Investors who wish to receive The Green Baron Report for free can join at  

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company's SEC filings. These risks and uncertainties could cause the Company's actual results to differ materially from those indicated in the forward-looking statements.

Company Contact Information:

BioDrain Medical, Inc.

2060 Centre Pointe Blvd, Suite 7

Mendota Heights, MN 55120

Phone: +1.651.389.4800

Fax: +1.651.379.5024

For additional requests, please visit:

SOURCE BioDrain Medical, Inc.